DE69609184D1 - Verfahren zur synthese von oligonukleotiden - Google Patents

Verfahren zur synthese von oligonukleotiden

Info

Publication number
DE69609184D1
DE69609184D1 DE69609184T DE69609184T DE69609184D1 DE 69609184 D1 DE69609184 D1 DE 69609184D1 DE 69609184 T DE69609184 T DE 69609184T DE 69609184 T DE69609184 T DE 69609184T DE 69609184 D1 DE69609184 D1 DE 69609184D1
Authority
DE
Germany
Prior art keywords
segments
solution
alcohol group
linkage
residual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69609184T
Other languages
English (en)
Other versions
DE69609184T2 (de
Inventor
Alan Livingston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
La Jolla Pharmaceutical Co
Original Assignee
La Jolla Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by La Jolla Pharmaceutical Co filed Critical La Jolla Pharmaceutical Co
Application granted granted Critical
Publication of DE69609184D1 publication Critical patent/DE69609184D1/de
Publication of DE69609184T2 publication Critical patent/DE69609184T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
DE69609184T 1995-06-07 1996-05-16 Verfahren zur synthese von oligonukleotiden Expired - Fee Related DE69609184T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/474,999 US5856464A (en) 1995-06-07 1995-06-07 Selective capping solution phase oligonucleotide synthesis
PCT/US1996/007100 WO1996040708A2 (en) 1995-06-07 1996-05-16 Improved methods for oligonucleotide synthesis

Publications (2)

Publication Number Publication Date
DE69609184D1 true DE69609184D1 (de) 2000-08-10
DE69609184T2 DE69609184T2 (de) 2001-02-15

Family

ID=23885823

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69609184T Expired - Fee Related DE69609184T2 (de) 1995-06-07 1996-05-16 Verfahren zur synthese von oligonukleotiden

Country Status (10)

Country Link
US (2) US5856464A (de)
EP (1) EP0830366B1 (de)
JP (1) JPH11510790A (de)
KR (1) KR19990022711A (de)
CN (1) CN1190973A (de)
AT (1) ATE194355T1 (de)
AU (1) AU694359B2 (de)
CA (1) CA2222440A1 (de)
DE (1) DE69609184T2 (de)
WO (1) WO1996040708A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856464A (en) * 1995-06-07 1999-01-05 Lajolla Pharmaceutical Company Selective capping solution phase oligonucleotide synthesis
DE69840216D1 (de) 1997-08-08 2008-12-24 Celmed Oncology Usa Inc Verfahren und Zubereitungen um Resistenz gegen biologische oder chemische Therapien zu Überwinden
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
WO1999037753A1 (en) * 1998-01-23 1999-07-29 Newbiotics, Inc. Enzyme catalyzed therapeutic agents
US6096899A (en) * 1998-04-14 2000-08-01 The Regents Of The University Of Michigan Cylic imidazole compounds having relatively low hydrogen content and relatively high nitrogen content and polymers formed therefrom
CA2378187C (en) * 1999-07-22 2011-09-13 Newbiotics, Inc. Methods for treating therapy-resistant tumors
US6683061B1 (en) * 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
US6451998B1 (en) 1999-10-18 2002-09-17 Agilent Technologies, Inc. Capping and de-capping during oligonucleotide synthesis
MXPA02005236A (es) * 1999-11-28 2004-03-19 Jolla Pharma Metodos de tratamiento de lupus con base en la afinidad de anticuerpos y metodos de separacion por exclusion y composiciones para el uso de los mismos.
US7135565B2 (en) * 2000-07-28 2006-11-14 Agilent Technologies, Inc. Synthesis of polynucleotides using combined oxidation/deprotection chemistry
DE60109047T2 (de) * 2000-09-07 2006-04-06 Avecia Biotechnology, Inc., Milford Synthone zur herstellung von oligonukleotiden
CA2441350A1 (en) 2001-01-19 2002-07-25 Newbiotics, Inc. Methods to treat autoimmune and inflammatory conditions
US20030114405A1 (en) * 2001-08-13 2003-06-19 Linnik Matthew D. Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function
DE10142643A1 (de) * 2001-08-31 2003-04-24 Clondiag Chip Tech Gmbh Detektion von Wechselwirkungen auf Sonden-Arrays
US7105135B2 (en) * 2001-10-16 2006-09-12 Lockheed Martin Corporation System and method for large scale detection of hazardous materials in the mail or in other objects
US6696298B2 (en) 2001-12-07 2004-02-24 Biosearch Technologies, Inc. Multi-channel reagent dispensing apparatus
AU2003303524A1 (en) * 2002-12-27 2004-07-29 La Jolla Pharmaceutical Company Methods of improving health-related quality of life in individuals with systemic lupus erythematosus
WO2004089422A2 (en) * 2003-03-30 2004-10-21 La Jolla Pharmaceutical Co. Methods of treating and monitoring systemic lupus erythematosus in individuals
US20070136064A1 (en) * 2003-04-16 2007-06-14 Carroll David W Mobile personal computer with movement sensor
WO2008045535A2 (en) * 2006-10-12 2008-04-17 Research Foundation Of The City University Of New York Convertible nucleoside derivatives
US20090007775A1 (en) * 2007-03-07 2009-01-08 Seymour John C Engine for Aeronautical Applications II
CN102344477B (zh) 2010-07-27 2015-04-08 苏州瑞博生物技术有限公司 一种核苷酸和/或寡核苷酸及其制备方法
US20190070212A1 (en) * 2016-03-11 2019-03-07 Spring Bank Pharmaceuticals, Inc. Compounds and compositions for the treatment of infections
CN111479818A (zh) * 2018-02-13 2020-07-31 深圳华大生命科学研究院 合成寡核苷酸的方法及系统
US20210197164A1 (en) * 2018-05-29 2021-07-01 Centrillion Technology Holdings Corporation Methods and systems for monitoring solid-phase stepwise oligonucleotide synthesis
KR20230154026A (ko) * 2021-02-08 2023-11-07 락티젠 세러퓨틱스 다가 올리고뉴클레오티드 작용제 및 이의 사용 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415732A (en) * 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US5430136A (en) * 1984-10-16 1995-07-04 Chiron Corporation Oligonucleotides having selectably cleavable and/or abasic sites
US5367066A (en) * 1984-10-16 1994-11-22 Chiron Corporation Oligonucleotides with selectably cleavable and/or abasic sites
US4959463A (en) * 1985-10-15 1990-09-25 Genentech, Inc. Intermediates
US5214134A (en) * 1990-09-12 1993-05-25 Sterling Winthrop Inc. Process of linking nucleosides with a siloxane bridge
CA2153505A1 (en) * 1993-01-08 1994-07-21 Jin-Yan Tang Synthesis of dimmer blocks and their use in assembling oligonucleotides
US5856464A (en) * 1995-06-07 1999-01-05 Lajolla Pharmaceutical Company Selective capping solution phase oligonucleotide synthesis

Also Published As

Publication number Publication date
US5856464A (en) 1999-01-05
WO1996040708A2 (en) 1996-12-19
CN1190973A (zh) 1998-08-19
EP0830366A2 (de) 1998-03-25
DE69609184T2 (de) 2001-02-15
KR19990022711A (ko) 1999-03-25
CA2222440A1 (en) 1996-12-19
ATE194355T1 (de) 2000-07-15
AU694359B2 (en) 1998-07-16
US6166198A (en) 2000-12-26
WO1996040708A3 (en) 1997-02-20
JPH11510790A (ja) 1999-09-21
EP0830366B1 (de) 2000-07-05
AU5752496A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
ATE194355T1 (de) Verfahren zur synthese von oligonukleotiden
Shibahara et al. Site-directed cleavage of RNA
Agarwal et al. Total synthesis of the gene for an alanine transfer ribonucleic acid from yeast
Khorana Nucleic acid synthesis
Ojala et al. tRNA punctuation model of RNA processing in human mitochondria
Holley et al. Chemistry of amino acid-specific ribonucleic acids
Acevedo et al. Non-enzymatic transcription of an oligodeoxynucleotide 14 residues long
Holley Structure of an alanine transfer ribonucleic acid
EP0375278A3 (de) Automatisches System zur Herstellung und Reinigung von Polynucleotiden
WO1994014972B1 (en) Method and apparatus for enzymatic synthesis of oligonucleotides
WO2001048184A3 (de) Verfahren zur parallelen sequenzierung eines nukleinsäuregemisches an einer oberfläche
ES2169071T3 (es) Derivados de cumarina no nucleosidicos como agentes de entrecruzamiento de polinucleotidos.
Thuong et al. Solid phase synthesis of oligo-α-and oligo-β-deoxynucleotidescovalently linked to an acridine
DE68909280D1 (de) Hydrierung aromatischer Amine zur Herstellung ihrer entsprechenden ringhydrierten Verbindungen.
Tanaka et al. Solid phase synthesis of oligoribonucleotides using the o-nitrobenzyl group for 2'-hydroxyl protection and H-phosphonate chemistry
EP0002322A2 (de) Ein verbessertes Triesterverfahren zur Herstellung von Oligonukleotiden
Hsiung et al. Synthesis of human insulin gene. Part I. Development of reversed-phase chromatography in the modified triester method. Its application in the rapid and efficient synthesis of eight deoxyribo-oligonucleotides fragments constituting human insulin A DNA
KRAWETZ et al. Cloning of bovine P1 protamine cDNA and the evolution of vertebrate P1 protamines
DE69424504T2 (de) Verfahren zur Herstellung von Etoposid-Phosphat und Etoposid
Usman et al. Preparation of glyceronucleoside phosphoramidite synthons and their use in the solid phase synthesis of acyclic oligonucleotides
DK0644196T3 (da) TTTr som beskyttelsesgruppe i nucleotidsyntesen
Ma et al. The 9‐fluorenylmethyloxycarbonyl group as a 5′‐OH protection in oligonucleotide synthesis
Yamana et al. A simple preparation of 5′-O-dimethoxytrityl deoxyribonucleoside 3′-O-phosphorbisdiethylamidites as useful intermediates in the synthesis of oligodeoxyribonucleotides and their phosphorodiethylamidate analogs on a solid support
Yamana et al. Deoxyribonucleoside 3′-phosphorobisamidites in the synthesis of isopropyl phosphotriester oligodeoxyribonucleotide analogues
Wilk et al. Backbone-modified oligonucleotides containing a butanediol-1, 3 moiety as a ‘vicarious segment’for the deoxyribosyl moiety—synthesis and enzyme studies

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee